Loading...
Mixed Asset Passive

RISE Healthcare Fixed Income Balanced (253290)

Update : 2026.05.07

NAV

12,607KRW

+0.46상승 (-%)

Market Price per share (KRW)

12,625KRW

+100상승 (0.8%)

※ t-1 last price

trading volume

29,448shares

AUM

KRW 22.6billion

RISE Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2026.05.07
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare Fixed Income Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 22,693,075,314
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 12,625
※ t-1 last price
12,607 29,448
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare Fixed Income Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
22,693,075,314 하나은행
Market Price per share (KRW) iNAV per share (KRW)
12,625
※ t-1 last price
12,607
Trading Volume (shares)
29,448
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2026-05-07
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB02500-3009(25-8) 26.96
2 KTB02875-2712(24-12) 17.06
3 RISE KTB 16.33
4 RISE HealthCare 12.40
5 KTB02250-2806(25-4) 5.57
6 KTB3 F 202606 2.74
7 Celltrion 2.30
8 SAMSUNG BIOLOGICS 1.94
9 Alteogen 1.79
10 HLB 1.77

proportion by sectors

*The proportion of investment stocks

Update : 2026.05.07
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-12-09 2025-12-11 50
2025-06-09 2025-06-11 50
2024-12-09 2024-12-11 90
2024-06-07 2024-06-11 40
2023-12-08 2023-12-12 110
2023-06-08 2023-06-12 40
2022-12-08 2022-12-12 91
2022-06-09 2022-06-13 16
2021-12-09 2021-12-13 11

Performance

performance

excel download

Update : 2026-05-07

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV -1.05 -3.47 -0.52 4.76 16.56 -1.29 31.84
Benchmark Index -0.84 -2.31 0.55 6.08 20.88 -0.25 41.01
Outperformance -0.22 -1.17 -1.07 -1.33 -4.32 -1.04 -9.17

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.05.04 12,625 0.798상승 12,606.8 -0.064하락 10,334.36
2026.04.30 12,525 -1.687하락 12,613.53 -1.231하락 10,340.09
2026.04.29 12,740 0.394상승 12,770.8 -0.127하락 10,352.89
2026.04.28 12,690 -1.589하락 12,787.05 -0.757하락 10,353.43
2026.04.27 12,895 0.077상승 12,884.64 0.698상승 10,360.25
2026.04.24 12,885 0.861상승 12,794.38 0.550상승 10,360.79
2026.04.23 12,775 0.353상승 12,724.3 -0.204하락 10,374.35
2026.04.22 12,730 -0.078하락 12,750.37 -0.754하락 10,393.07
2026.04.21 12,740 -0.624하락 12,847.34 -0.575하락 10,395.94
2026.04.20 12,820 -0.155하락 12,921.71 -0.100하락 10,390.04
2026.04.17 12,840 -1.116하락 12,933.86 -0.286하락 10,385.65
2026.04.16 12,985 0.815상승 12,971.04 -0.120하락 10,391.6
2026.04.15 12,880 1.218상승 12,986.68 1.534상승 10,392.79
2026.04.14 12,725 0.592상승 12,790.44 0.357상승 10,389.26
2026.04.13 12,650 -0.118하락 12,744.93 -0.201하락 10,383.53
2026.04.10 12,665 0.039상승 12,769.8 0.165상승 10,390.14
2026.04.09 12,660 -0.627하락 12,748.75 -0.038하락 10,396.66
2026.04.08 12,740 1.513상승 12,753.64 1.061상승 10,389.31
2026.04.07 12,550 -0.672하락 12,619.67 -0.604하락 10,364.67

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 KTB02500-3009(25-8) KR103503GF95 714,285,714 26.96 679,682,142
2 KTB02875-2712(24-12) KR103501GEC6 428,571,429 17.06 430,177,286
3 RISE KTB KR7114100001 3,850 16.33 411,815,250
4 RISE HealthCare KR7253280002 19,141 12.4 312,572,530
5 KTB02250-2806(25-4) KR103501GF63 142,857,143 5.57 140,429,714
6 KTB3 F 202606 KR4A65660008 0.67 2.74 68,986,701
7 Celltrion KR7068270008 293 2.3 57,955,400
8 SAMSUNG BIOLOGICS KR7207940008 33 1.94 49,005,000
9 Alteogen KR7196170005 121 1.79 45,133,000
10 HLB KR7028300002 732 1.77 44,578,800
11 SCD KR7000250001 87 1.41 35,626,500
12 ABL Bio KR7298380007 260 1.37 34,450,000
13 Yuhan KR7000100008 347 1.25 31,403,500
14 LCB KR7141080002 164 1.18 29,766,000
15 원화예금 KRD010010001 25,245,070 1 25,245,070
16 HanmiPharm KR7128940004 39 0.69 17,355,000
17 SKBP KR7326030004 170 0.67 16,881,000
18 PharmaResearch KR7214450009 42 0.56 14,238,000
19 ST Pharm KR7237690003 81 0.49 12,457,800
20 HANALL BIOPHARMA KR7009420001 220 0.4 10,186,000
21 Hugel KR7145020004 33 0.34 8,629,500
22 CLASSYS KR7214150005 134 0.3 7,544,200
23 Celltrionph KR7068760008 128 0.28 7,116,800
24 Pharmicell KR7005690003 349 0.28 7,067,250
25 SKBS KR7302440003 165 0.28 7,144,500
26 L&C BIO KR7290650001 104 0.26 6,531,200
27 CHA Biotech KR7085660009 337 0.23 5,695,300
28 ORUM KR7475830006 59 0.22 5,540,100
29 SEEGENE KR7096530001 200 0.19 4,900,000
30 GC Biopharma Corp. KR7006280002 34 0.19 4,675,000
31 Hanmi Science KR7008930000 127 0.19 4,832,350
32 HK inno.N KR7195940002 89 0.18 4,628,000
33 CHONGKUNDANG KR7185750007 49 0.17 4,218,900
34 DAEWOONG PHARM KR7069620003 28 0.16 4,135,600
35 DongKook Pharm KR7086450004 147 0.14 3,491,250
36 MedyTox KR7086900008 34 0.14 3,587,000
37 ILDONG PHARM KR7249420001 131 0.13 3,399,450
38 CUREXO KR7060280005 181 0.12 2,932,200
39 HLBPHARMA KR7047920004 174 0.12 3,004,980
40 Daewoong KR7003090008 123 0.11 2,755,200
41 i-SENS KR7099190001 130 0.11 2,834,000
42 EuBio KR7206650004 194 0.1 2,465,740
43 DENTIUM KR7145720009 41 0.09 2,164,800
44 ShinpoongPharm KR7019170000 206 0.09 2,356,640
45 Binex KR7053030003 179 0.08 1,967,210
46 Huons Global KR7084110006 34 0.08 2,108,000
47 SELVAS AI KR7108860008 148 0.08 1,929,920
48 WONTECH KR7336570007 270 0.08 1,971,000
49 BioPlus KR7099430001 264 0.06 1,549,680
50 Humedix KR7200670008 37 0.05 1,319,050
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.